Factors Affecting First-Line Triple Therapy of Helicobacter pylori Including CYP2C19 Genotype and Antibiotic Resistance

被引：0
作者：
Ju Yup Lee
Nayoung Kim
Min Soo Kim
Yoon Jin Choi
Jung Won Lee
Hyuk Yoon
Cheol Min Shin
Young Soo Park
Dong Ho Lee
Hyun Chae Jung
机构：
[1] Seoul National University Bundang Hospital,Department of Internal Medicine
[2] Seoul National University College of Medicine,Department of Internal Medicine and Liver Research Institute
来源：
Digestive Diseases and Sciences | 2014年 / 59卷
关键词：
Clarithromycin; Treatment failure; Drug resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1235 / 1243
页数：8
相关论文
共 50 条
[21]   Pharmacokinetic- pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori [J].
Yang, Jyh-Chin ;
Yang, Yu-Fan ;
Uang, Yow-Shieng ;
Lin, Chun-Jung ;
Wang, Teh-Hong .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (05) :503-510
[22]   Hp-normogram (normo-graham) for Assessing the Outcome of H-pylori Therapy: Effect of Resistance, Duration, and CYP2C19 Genotype [J].
Graham, David Y. .
HELICOBACTER, 2016, 21 (02) :85-90
[23]   Clopidogrel resistance in extremely high cardiovascular risk patients with genotype CYP2C19 [J].
Cardenas, Liliana ;
Aymen Abdullah, Ali ;
Jaramillo, Gabriela ;
Cardenas, Paul ;
Galvez, Gabriela ;
Hidalgo, Fernando .
REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2023, 52 (03) :134-137
[24]   Comparison of the traditional triple and a new bismuth-containing quadruple therapy in the first-line eradication of Helicobacter pylori [J].
Varga Mate ;
Dracz Lajos ;
Kolbenheyer Erik ;
Varga Ferenc ;
Patai Arpad, V ;
Solymosi Norbert ;
Patai Arpad .
ORVOSI HETILAP, 2019, 160 (34) :1340-1345
[25]   Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori [J].
Wu, Meng-Chieh ;
Wang, Yao-Kuang ;
Liu, Chung-Jung ;
Yu, Fang-Jung ;
Kuo, Fu-Chen ;
Liu, Min-Li ;
Kuo, Chao-Hung ;
Wu, Deng-Chyang ;
Huang, Yao-Kang ;
Wu, I-Chen .
GASTROENTEROLOGY RESEARCH AND PRACTICE, 2017, 2017
[26]   Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori [J].
Castro-Fernandez, M. ;
Lamas, E. ;
Perez-Pastor, A. ;
Pabon, M. ;
Aparcero, R. ;
Vargas-Romero, J. ;
Larraona, J. L. ;
Romero-Gomez, M. .
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2009, 101 (06) :395-398
[27]   Bismuth containing quadruple therapy versus tailored therapy as first-line treatments for Helicobacter pylori infection in a high clarithromycin resistance area [J].
Cha, Boram ;
Bang, Byoung Wook ;
Shin, Jong Beom ;
Ko, Eun Jung ;
Ko, Weonjin ;
Kwon, Kye Sook ;
Shin, Yong Woon ;
Suh, Young Ju ;
Kim, Hyungkil .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (09) :1017-1022
[28]   Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection [J].
Ang, Tiing Leong ;
Fock, Kwong Ming ;
Song, Mingjun ;
Ang, Daphne ;
Kwek, Andrew Boon Eu ;
Ong, Jeannie ;
Tan, Jessica ;
Teo, Eng Kiong ;
Dhamodaran, Subbiah .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (07) :1134-1139
[29]   The Efficacy of Bismuth Quadruple Therapy, Sequential Therapy, and Hybrid Therapy as a First-Line Regimen for Helicobacter pylori Infection Compared with Standard Triple Therapy [J].
Koroglu, M. ;
Ayvaz, M. A. ;
Ozturk, M. A. .
NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2022, 25 (09) :1535-1541
[30]   Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori [J].
Adachi, Teppei ;
Matsui, Shigenaga ;
Watanabe, Tomohiro ;
Okamoto, Kazuki ;
Okamoto, Ayana ;
Kono, Masashi ;
Yamada, Mitsunari ;
Nagai, Tomoyuki ;
Komeda, Yoriaki ;
Minaga, Kosuke ;
Kamata, Ken ;
Yamao, Kentaro ;
Takenaka, Mamoru ;
Asakuma, Yutaka ;
Sakurai, Toshiharu ;
Nishida, Naoshi ;
Kashida, Hiroshi ;
Kudo, Masatoshi .
ONCOLOGY, 2017, 93 :15-19
12345